Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Explosion Of Interest In Organ-On-A-Chip Technology

    Nov 25, 2019, 09:05 AM by Michael Croft

    Bio-IT World | Organ-on-a-chip models were practically nonexistent a decade ago, but significant advances are now being made every few months.

    Full story
  • Debiopharm Implements Dotmatics to Improve Data-Driven Decision-Making

    Nov 25, 2019, 06:10 AM by Michael Croft
    BISHOP'S STORTFORD, UNITED KINGDOM - Nov 25, 2019 - Debiopharm International SA, the drug development company focused on oncology and infectious diseases, has implemented tools from Dotmatics, a leading provider of scientific informatics solutions and services, to re-engineer its data management processes to support its continuous growth
    Full story
  • Potential findings on whole genome sequencing for cancer treatment was made

    Nov 24, 2019, 16:39 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Nov 25, 2019 - In recent years, individualized treatments will benefit more cancer patients as the time and cost of whole genome sequencing decreases
    Full story
  • Follow The Money: Investments and Funding Rounds for November

    Nov 22, 2019, 14:30 PM by Michael Croft

    Bio-IT World | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.

    Full story
  • Hesperos: A CRO For Body-On-A-Chip Enthusiasts

    Nov 22, 2019, 08:00 AM by Michael Croft

    Bio-IT World | Operationally, Hesperos works much like a contract research organization that delivers study results back to sponsoring companies, with its specialty being integration assistance to drug developers interested in using a multiorgan model for their preclinical efficacy and toxicity studies.

    Full story
  • Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285

    Nov 21, 2019, 09:42 AM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist
    Full story
  • Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution

    Nov 21, 2019, 09:03 AM by Michael Croft
    PRINCETON, NJ - Nov 21, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the availability of PK Submit™, a technology solution for automating the creation of PK Clinical Data Interchange Standards Consortium (CDISC) domains during Non-Compartmental Analysis (NCA)
    Full story
  • Organs On Chips Will Make Drugs Safer—And More Precise

    Nov 21, 2019, 06:45 AM by Michael Croft

    Bio-IT World | The emergence of organ-on-a-chip systems to expedite drug discovery and toxicology studies is a process more than three decades in the making.

    Full story
  • Elsevier joins forces with Food and Drug Administration to build predictive drug-induced liver injury AI algorithm

    Nov 21, 2019, 05:42 AM by Michael Croft
    NEW YORK, NY - Nov 21, 2019 - Elsevier, a global information analytics business specializing in science and health, has entered into a Collaborative Research and Development Agreement (CRADA) with the National Center for Toxicological Research (NCTR) at the Food and Drug Administration (FDA)
    Full story
  • Creative Proteomics Has Made Targeted Metabolomics Service More Perfect

    Nov 21, 2019, 01:33 AM by Michael Croft
    SHIRLEY, NY - Nov 21, 2019 - November 21, 2019, as an integrated company and leading supplier in the field of proteomics, metabolomics, glycomics, and bioinformatics analysis services, Creative Proteomics has introduced its newly-updated service--targeted metabolomics to assist biotech researchers of their clients
    Full story
  • Accumen Launches New Website to Showcase Its Expanded Range of Technologies and Services to Optimize Healthcare Performance

    Nov 20, 2019, 11:21 AM by Michael Croft
    PHOENIX, AZ - Nov 20, 2019 - Accumen Inc., the leader in healthcare performance, today announced the launch of its new website at www
    Full story
  • Mologic launches clinical trial for validation of point-of-care COPD exacerbation alert system

    Nov 20, 2019, 09:10 AM by Michael Croft
    BEDFORDSHIRE, UNITED KINGDOM - Nov 20, 2019 -
    • COPE-WEL study aims to validate Headstart® test for early detection and monitoring of pulmonary exacerbation of COPD
    • Headstart is a non-invasive self-test that detects lung biomarkers in the urine
    • Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres
     Bedfordshire, UK, 20 November 2019: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company's urine-based multi-biomarker self-test, Headstart®, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
    Full story
  • Will Organ-On-A-Chip Models Be Viable Alternatives to Animal Testing?

    Nov 20, 2019, 07:50 AM by Michael Croft

    Bio-IT World | A new testing technology is of great interest to pharmaceutical companies looking to better understand the effects of medicines—especially the unintended consequences of their administration—and will facilitate study of not only toxicity, but also the mechanism by which drugs work and the timing of their delivery and physiological response.

    Full story
  • Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop

    Nov 20, 2019, 06:06 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Nov 19, 2019 - Optibrium™, BioSolveIT™ and Enamine™, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s StarDrop™ software
    Full story
  • Creative Biolabs Announced cd25 Monoclonal Antibody for Research Use

    Nov 19, 2019, 01:24 AM by Michael Croft
    SHIRLEY, NY - Nov 19, 2019 - November 19, 2019, as a leading supplier in the recombinant antibody field, Creative Biolabs aims to provide high-quality services and products to clients in the academia and industry fields all over the world
    Full story
  • ScaleMatrix’ DDC Technology Enables Enterprises to Deploy 13 PFLOP NVIDIA DGX-powered ‘AI Anywhere’ Infrastructure with Flexible, ‘No Data Center Required’ Design

    Nov 18, 2019, 19:24 PM by Michael Croft
    DENVER, CO - Nov 18, 2019 - ScaleMatrix, through its subsidiary company, DDC, the global leader in providing scalable data center-to-edge solutions based on its patented Dynamic Density Control™ (DDC) cabinet technology, today announced that it is collaborating with NVIDIA and Microway to deliver SKUs for an 8 petaFLOPS and a 13 petaFLOPS 'Supercomputer Anywhere' solution using its DDC S-Series cabinetsx
    Full story
  • Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland

    Nov 18, 2019, 13:29 PM by Michael Croft
    KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
    Full story
  • Life Image and Graticule Launch GLIMPS in the New AWS Data Exchange

    Nov 18, 2019, 12:50 PM by Michael Croft
    NEWTON, MA, UNITED STATES - Nov 18, 2019 - Life Image, one of the world’s largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule, an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloud
    Full story
  • TOP500 Supercomputers List Announced

    Nov 18, 2019, 12:06 PM by Michael Croft
    TOP500 | The 54th edition of the TOP500 saw China and the US maintaining their dominance of the list, albeit in different categories.
    Full story
  • Reducing Wasted Life Science Research By Using Factorial Experiments

    Nov 18, 2019, 10:30 AM by Michael Croft

    Bio-IT World Contributed Commentary | To combat the waste of life science research, Sridhar Iyengar advocates building comprehensive lab monitoring and information systems that, using "AI", can "correlate fluctuations in many different variables" to deviations in observed results. There is, however, another completely different approach to tease out from the "myriad factors": factorial experimentation, in particular, 2-level screening experiments.

    Full story
  • «
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy